Bruker Corporation to Host Investor Webinar on May 17, 2024
May 09 2024 - 7:00AM
Business Wire
Bruker Corporation (Nasdaq: BRKR) today announced it intends to
hold an Investor Webinar from 10 am to about 12 noon Eastern
Daylight Time (EDT) on May 17, 2024, to provide additional insights
into its three recent acquisitions of Chemspeed, ELITech, and of
the NanoString business. Bruker also expects to provide an update
to its medium-term financial outlook.
The Investor Webinar will include presentations by CEO Frank H.
Laukien, CFO Gerald Herman, and by the leaders of these three new
Bruker businesses, all followed by a live Q&A session for
analysts and investors.
A link to the Investor Webinar will be available in the Events
& Presentations section of the Company’s Investor Relations
website at https://ir.bruker.com. A replay will be available on
Bruker’s Investor Relations website after the conclusion of the
event.
About Bruker Corporation – Leader of the Post-Genomic Era
(Nasdaq: BRKR)
Bruker is enabling scientists and engineers to make breakthrough
post-genomic discoveries and develop new applications that improve
the quality of human life. Bruker’s high-performance scientific
instruments and high-value analytical and diagnostic solutions
enable scientists to explore life and materials at molecular,
cellular, and microscopic levels. In close cooperation with our
customers, Bruker is enabling innovation, improved productivity,
and customer success in post-genomic life science molecular and
cell biology research, in applied and biopharma applications, in
microscopy and nanoanalysis, as well as in industrial and cleantech
research, and next-gen semiconductor metrology in support of AI.
Bruker offers differentiated, high-value life science and
diagnostics systems and solutions in preclinical imaging, clinical
phenomics research, proteomics and multiomics, spatial and
single-cell biology, functional structural and condensate biology,
as well as in clinical microbiology and molecular diagnostics. For
more information, please visit www.bruker.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240509874955/en/
Justin Ward Sr. Director, Investor Relations & Corporate
Development Bruker Corporation T: +1 (978) 313-5800 E:
Investor.Relations@bruker.com
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Sep 2024 to Oct 2024
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Oct 2023 to Oct 2024